See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Motorsports
Donald Trump
Social Media
Pope Francis
Natural Disasters
US Politics
Premier League
Wrestling
Conclave
Soccer
Champions League
Published • loading... • Updated

Eli Lilly’s stock plunges as investors eye obesity-drug competition

Summary by MarketWatch
Eli Lilly & Co.’s stock was on pace for its worst day in about three years Thursday as investors fretted about intensifying competition among obesity-drug developers.

1 Articles

All
Left
Center
1
Right
MarketWatchMarketWatch
Center

Eli Lilly’s stock plunges as investors eye obesity-drug competition

Eli Lilly & Co.’s stock was on pace for its worst day in about three years Thursday as investors fretted about intensifying competition among obesity-drug developers.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MarketWatch broke the news in United States on Thursday, July 18, 2024.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets

Stock Markets

Eli Lilly

Eli Lilly

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal